Composition
- Active ingredients
- ROLAPITANT HYDROCHLORIDE EQ 166.5MG BASE/92.5ML (EQ 1.8MG BASE/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ROLAPITANT HYDROCHLORIDE EQ 90MG BASE · TabletNDA206500-001 · Prescription
- ROLAPITANT HYDROCHLORIDE EQ 166.5MG BASE/92.5ML (EQ 1.8MG BASE/ML) · EmulsionThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA208399.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Varubi
- Active substance
- rolapitant hydrochloride
- Route
- Intravenous
- Dosage form
- Emulsion
- Applicant
- Tersera
- Status
- Discontinued
- FDA approval
- 25 Oct 2017
- Application
- NDA208399-001